Results 141 to 150 of about 8,714 (152)

[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Translational Medicine Branch   +5 more
europepmc   +1 more source

[p53-SOAT1 Axis: A Novel Target for Tumor Lipid Metabolism and Therapy]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi
Yu X, Xiao Y, Xu B, Li X, Wang H, Ren D.
europepmc   +1 more source

[Drug repositioning prediction based on dynamic feature learning on heterogeneous graphs]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Zhu H, Guo Y, Xin X, Li C, Zhou D.
europepmc   +1 more source

[Clinical Progress and Prospects of mRNA Tumor Drugs]. [PDF]

open access: yesSichuan Da Xue Xue Bao Yi Xue Ban
Chen J   +5 more
europepmc   +1 more source

[Research Progress of TNMB Staging in Lung Cancer]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi
Zhan Y, Li Y, Shen C.
europepmc   +1 more source

[Prognostic analysis of laparoscopic simultaneous radical cystectomy and nephroureterectomy]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Li S   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy